312
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Multiple e-Pharmacophore modeling to identify a single molecule that could target both streptomycin and paromomycin binding sites for 30S ribosomal subunit inhibition

, , ORCID Icon, , & ORCID Icon
Pages 1582-1596 | Received 23 Nov 2017, Accepted 21 Mar 2018, Published online: 07 May 2018

References

  • Agrawal, R. K., Penczek, P., Grassucci, R. A., Li, Y., Leith, A., Nierhaus, K. H., & Frank, J. (1996). Direct visualization of A-, P-, and E-site transfer RNAs in the Escherichia coli ribosome. Science, 271, 1000–1002.10.1126/science.271.5251.1000
  • Auerbach, T., Bashan, A., & Yonath, A. (2004). Ribosomal antibiotics: Structural basis for resistance, synergism and selectivity. Trends in Biotechnology, 22, 570–576.10.1016/j.tibtech.2004.09.006
  • Carter, A. P., Clemons, W. M., Brodersen, D. E., Morgan-Warren, R. J., Hartsch, T., Wimberly, B. T., & Ramakrishnan, V. (2001). Crystal structure of an initiation factor bound to the 30S ribosomal subunit. Science, 291, 498–501.10.1126/science.1057766
  • Carter, A. P., Clemons, W. M., Brodersen, D. E., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000). Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature, 407, 340–348.
  • Chellat, M. F., Raguž, L., & Riedl, R. (2016). Targeting antibiotic resistance. Angewandte Chemie International Edition, 55, 6600–6626.10.1002/anie.201506818
  • Daniels, P. J., Weinstein, J., Tkach, R. W., & Morton, J. (1974). Gentamicin derivatives modified at the 2’-position. The Journal of Antibiotics, 27, 150–154.10.7164/antibiotics.27.150
  • Demeshkina, N., Jenner, L., Westhof, E., Yusupov, M., & Yusupova, G. (2012). A new understanding of the decoding principle on the ribosome. Nature, 484, 256–259.10.1038/nature10913
  • Demirci, H., Murphy, F. T., Murphy, E., Gregory, S. T., Dahlberg, A. E., & Jogl, G. (2013). A structural basis for streptomycin-induced misreading of the genetic code. Nature Communications, 4, 1355.10.1038/ncomms2346
  • Dixon, S. L., Smondyrev, A. M., & Rao, S. N. (2006). PHASE: A novel approach to pharmacophore modeling and 3D database searching. Chemical Biology and Drug Design, 67, 370–372.10.1111/jpp.2006.67.issue-5
  • Dong, J., Cao, D. S., Miao, H. Y., Liu, S., Deng, B. C., Yun, Y. H., … Chen, A. F. (2015). ChemDes: An integrated web-based platform for molecular descriptor and fingerprint computation. Journal of Cheminformatics, 7, 205.10.1186/s13321-015-0109-z
  • Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., … Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47, 1739–1749.10.1021/jm0306430
  • Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., … Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein−Ligand complexes. Journal of Medicinal Chemistry, 49, 6177–6196.10.1021/jm051256o
  • Gooch, A., Sizochenko, N., Rasulev, B., Gorb, L., & Leszczynski, J. (2017). In vivo toxicity of nitroaromatics: A comprehensive quantitative structure-activity relationship study. Environmental Toxicology and Chemistry, 36(8), 2227–2233.10.1002/etc.v36.8
  • Gramatica, P., Chirico, N., Papa, E., Cassani, S., & Kovarich, S. (2013). QSARINS: A new software for the development, analysis, and validation of QSAR MLR models. Journal of Computational Chemistry, 34, 2121–2132.10.1002/jcc.v34.24
  • Gupta, S., Fallarero, A., Jarvinen, P., Karlsson, D., Johnson, M. S., Vuorela, P. M., & Mohan, C. G. (2011). Discovery of dual binding site acetylcholinesterase inhibitors identified by pharmacophore modeling and sequential virtual screening techniques. Bioorganic & Medicinal Chemistry Letters, 21, 1105–1112.10.1016/j.bmcl.2010.12.131
  • Gupta, S., & Mohan, C. G. (2014). Dual binding site and selective acetylcholinesterase inhibitors derived from integrated pharmacophore models and sequential virtual screening. BioMed research international 2014, 291214.
  • Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47, 1750–1759.10.1021/jm030644s
  • Hardesty, B, & Kramer, G. (2012). Structure, function, and genetics of ribosomes. Springer-Verlag New York: Springer Science & Business Media.
  • Hong, W., Zeng, J., & Xie, J. (2014). Antibiotic drugs targeting bacterial RNAs. Acta Pharmaceutica Sinica B, 4, 258–265.10.1016/j.apsb.2014.06.012
  • Jha, P., Chaturvedi, S., Swastika, P. S., Jain, N., & Mishra, A. K. (2017). Improvising 5-HT 7 R homology model for design of high affinity ligands: Model validation with docking, embrace minimization, MM-GBSA, and molecular dynamic simulations. Journal of Biomolecular Structure and Dynamics: 1–20. doi:10.1080/07391102.2017.1359907
  • Jia, B., Gan, X., & Gu, M. (2008). Strong tangential force within a small trapping volume under near-field Laguerre-Gaussian beam illumination. Optics Express, 16, 15191–15197.10.1364/OE.16.015191
  • Karabulut, S., Sizochenko, N., Orhan, A., & Leszczynski, J. (2016). A DFT-based QSAR study on inhibition of human dihydrofolate reductase. Journal of Molecular Graphics and Modelling, 70, 23–29.10.1016/j.jmgm.2016.09.005
  • Kurland, C. G. (1992). Translational accuracy and the fitness of bacteria. Annual Review of Genetics, 26, 29–50.10.1146/annurev.ge.26.120192.000333
  • Kuz’min, V. E., Artemenko, A. G., & Muratov, E. N. (2008). Hierarchical QSAR technology based on the Simplex representation of molecular structure. J Comput Aided Mol Des, 22, 403–421.
  • Levin, B. R., McCall, I. C., Perrot, V., Weiss, H., Ovesepian, A., & Baquero, F. (2017). A numbers game: Ribosome densities, bacterial growth, and antibiotic-mediated stasis and death. Mbio, 8, e02253–02216.
  • LigPrep Schrödinger, LLC, New York, NY. 2016.
  • Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44, 235–249.10.1016/S1056-8719(00)00107-6
  • Lyne, P. D., Lamb, M. L., & Saeh, J. C. (2006). Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. Journal of Medicinal Chemistry, 49, 4805–4808.10.1021/jm060522a
  • Malik, R., Choudhary, B. S., Srivastava, S., Mehta, P., & Sharma, M. (2017). Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 35, 3268–3284.10.1080/07391102.2016.1253503
  • Ogle, J. M., Brodersen, D. E., Clemons Jr., W. M., Tarry, M. J., Carter, A. P., & Ramakrishnan, V. (2001). Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science, 292, 897–902.10.1126/science.1060612
  • Ogle, J. M., Carter, A. P., & Ramakrishnan, V. (2003). Insights into the decoding mechanism from recent ribosome structures. Trends in Biochemical Sciences, 28, 259–266.10.1016/S0968-0004(03)00066-5
  • Ogle, J. M., Murphy, F. V., Tarry, M. J., & Ramakrishnan, V. (2002). Selection of tRNA by the ribosome requires a transition from an open to a closed form. Cell, 111, 721–732.10.1016/S0092-8674(02)01086-3
  • Okamoto-Hosoya, Y., Sato, T. A., & Ochi, K. (2000). Resistance to paromomycin is conferred by rpsL mutations, accompanied by an enhanced antibiotic production in Streptomyces coelicolor A3(2). The Journal of Antibiotics, 53, 1424–1427.10.7164/antibiotics.53.1424
  • Panecka, J., Mura, C., & Trylska, J. (2014). Interplay of the bacterial ribosomal A-site, S12 protein mutations and paromomycin binding: A molecular dynamics study. PLoS ONE, 9, e111811.10.1371/journal.pone.0111811
  • Panicker, P. S., Melge, A. R., Biswas, L., Keechilat, P., & Mohan, C. G. (2017). Epidermal growth factor receptor (EGFR) structure-based bioactive pharmacophore models for identifying next-generation inhibitors against clinically relevant EGFR mutations. Chemical Biology & Drug Design, 90(4), 629–636.10.1111/cbdd.2017.90.issue-4
  • Pape, T., Wintermeyer, W., & Rodnina, M. V. (1998). Complete kinetic mechanism of elongation factor Tu-dependent binding of aminoacyl-tRNA to the A site of the E. coli ribosome. The EMBO Journal, 17, 7490–7497.10.1093/emboj/17.24.7490
  • Peddi, S. R., Sivan, S. K., & Manga, V. (2018). Molecular dynamics and MM/GBSA-integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors. Journal of Biomolecular Structure and Dynamics, 36, 486–503.10.1080/07391102.2017.1281762
  • Phase Schrödinger, LLC, New York, NY. 2016.
  • Pratim Roy, P., Paul, S., Mitra, I., & Roy, K. (2009). On two novel parameters for validation of predictive QSAR models. Molecules, 14, 1660–1701.10.3390/molecules14051660
  • Pushkaran, A. C., Nataraj, N., Nair, N., Gotz, F., Biswas, R., & Mohan, C. G. (2015). Understanding the structure-function relationship of lysozyme resistance in staphylococcus aureus by peptidoglycan O-acetylation using molecular docking, dynamics, and lysis assay. Journal of Chemical Information and Modeling, 55, 760–770.10.1021/ci500734 k
  • QikProp, S., LLC, New York, NY Schrödinger, LLC, New York, NY. 2016.
  • Salam, N. K., Nuti, R., & Sherman, W. (2009). Novel method for generating structure-based pharmacophores using energetic analysis. Journal of Chemical Information and Modeling, 49, 2356–2368.10.1021/ci900212v
  • Sanbonmatsu, K., & Joseph, S. (2003). Understanding discrimination by the ribosome: Stability testing and groove measurement of codon–anticodon pairs. Journal of Molecular Biology, 328, 33–47.10.1016/S0022-2836(03)00236-5
  • Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27, 221–234.10.1007/s10822-013-9644-8
  • Saxena, S., Abdullah, M., Sriram, D., & Guruprasad, L. (2017). Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: Homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 1–15. doi:10.1080/07391102.2017.1384398
  • Selmer, M., Dunham, C. M., Murphy, F. V., Weixlbaumer, A., Petry, S., Kelley, A. C., … Ramakrishnan, V. (2006). Structure of the 70S ribosome complexed with mRNA and tRNA. Science, 313, 1935–1942.10.1126/science.1131127
  • Sharma, D., Cukras, A. R., Rogers, E. J., Southworth, D. R., & Green, R. (2007). Mutational analysis of S12 protein and implications for the accuracy of decoding by the ribosome. Journal of Molecular Biology, 374, 1065–1076.10.1016/j.jmb.2007.10.003
  • Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007). Epik: A software program for pKa a prediction and protonation state generation for drug-like molecules. Journal of Computer-Aided Molecular Design, 21, 681–691.10.1007/s10822-007-9133-z
  • Sohmen, D., Harms, J. M., Schlunzen, F., & Wilson, D. N. (2009a). Enhanced snapShot: Antibiotic inhibition of protein synthesis II. Cell, 139(212–212), e211.
  • Sohmen, D., Harms, J. M., Schlunzen, F., & Wilson, D. N. (2009b). SnapShot: Antibiotic inhibition of protein synthesis I. Cell, 138(1248), e1241.
  • Springer, B., Kidan, Y. G., Prammananan, T., Ellrott, K., Bottger, E. C., & Sander, P. (2001). Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance. Antimicrobial Agents and Chemotherapy, 45, 2877–2884.10.1128/AAC.45.10.2877-2884.2001
  • Stark, H., Orlova, E. V., Rinke-Appel, J., Junke, N., Mueller, F., Rodnina, M., … van Heel, M. (1997). Arrangement of tRNAs in pre- and posttranslocational ribosomes revealed by electron cryomicroscopy. Cell, 88, 19–28.10.1016/S0092-8674(00)81854-1
  • Truchon, J. F., & Bayly, C. I. (2007). Evaluating virtual screening methods: good and bad metrics for the “early recognition” problem. Journal of Chemical Information and Modeling, 47, 488–508.10.1021/ci600426e
  • Vijayrajratnam, S., Pushkaran, A. C., Balakrishnan, A., Vasudevan, A. K., Biswas, R., & Mohan, C. G. (2016). Bacterial peptidoglycan with amidated meso-diaminopimelic acid evades NOD1 recognition: An insight into NOD1 structure-recognition. Biochemical Journal, 473, 4573–4592.10.1042/BCJ20160817
  • Vilar, S., Uriarte, E., Santana, L., Lorberbaum, T., Hripcsak, G., Friedman, C., & Tatonetti, N. P. (2014). Similarity-based modeling in large-scale prediction of drug-drug interactions. Nature Protocols, 9, 2147–2163.10.1038/nprot.2014.151
  • Weissbach, H. (2012). Molecular mechanisms of protein biosynthesis. California: Elsevier.
  • Wilson, D. N. (2009). The A-Z of bacterial translation inhibitors. Critical Reviews in Biochemistry and Molecular Biology, 44, 393–433.10.3109/10409230903307311
  • Wilson, D. N. (2014). Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nature Reviews Microbiology, 12, 35–48.10.1038/nrmicro3155
  • Wimberly, B. T., Brodersen, D. E., Clemons, W. M., Jr, Morgan-Warren, R. J., Carter, A. P., Vonrhein, C., … Ramakrishnan, V. (2000). Structure of the 30S ribosomal subunit. Nature, 407, 327–339.
  • Wright, J. J., Cooper, A., Daniels, P. J., Nagabhushan, T. L., Rane, D., Turner, W. N., & Weinstein, J. (1976). Selective N-actylation of gentamicin antibiotics-synthesis of 1-N-acyl derivatives. J Antibiot (Tokyo), 29, 714–719.
  • Yilmaz, H., Sizochenko, N., Rasulev, B., Toropov, A., Guzel, Y., Kuz’Min, V., Leszczynska, D., & Leszczynski, J. (2015). Amino substituted nitrogen heterocycle ureas as kinase insert domain containing receptor (KDR) inhibitors: Performance of structure–activity relationship approaches. Journal of Food and Drug Analysis, 23, 168–175.10.1016/j.jfda.2015.03.001

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.